As shown in Figure S4C (Supporting Information), the expression level of caspase‐3 was significantly reduced before/after treatment of Casp‐GNMT by ELISA assay in injury and progressive phases of PF, demonstrating that Casp‐GNMT could treat PF in relation to consume caspase‐3. Here, GNMT is linked to pemphigus foliaceus.